Coxib controversy rumbles on
A couple of months after Merck pulled the plug on Vioxx due to cardiovascular …
Visit SiteBlogsarstechnica.com
Smoother toner could lead to smaller, cheaper color laser printersarstechnica.com
Hands on with the Project Sylpheed demoarstechnica.com
iPhone (web) apps emerging in spite of missing SDKarstechnica.com
FCC network neutrality comments due tomorrowarstechnica.com
Not just iTunes anymore: EMI unlocks DRM-free music for other retailersarstechnica.com
WildCharge to release wire-free charger for your gadgetsarstechnica.com
Contact tracing: Italy's open-source app finally lands, taking the Google-Apple modelzdnet.com
Are cancers fueled by stem cells?arstechnica.com
A visual timeline of the Microsoft-Novell controversyarstechnica.com
Changes ahead for e-voting; FL-13 controversy continuesarstechnica.com
œWe have limited ability to ‘push back.’â€theverge.com
MacBook "hack" controversy deconstructedarstechnica.com
MySpace sued in wake of sexual assaultarstechnica.com
What's going on at the FDA?arstechnica.com
Today’s Vergecast: DLSS 5 explained, with Linus Tech Tips.theverge.com
Garmin Connect is breaking smartwatches for iPhone users, but these fixes have worked for sometechradar.com
Christian Influencers Are Throwing Their Hatch Clocks in the Trashwired.com
NordVPN Review (2025): Living Up to Its Namewired.com
From Queer-Baiting to Neurodivergence: ‘Heated Rivalry’ Author Tackles Fan Theories and Controversywired.com
.jpg)
The Age of the All-Access AI Agent Is Herewired.com